1. Inici
  2. Sistema de Salut de Catalunya
  3. Enviaments recents

Sistema de Salut de Catalunya: Enviaments recents

Ara mostrant els elements 361-380 de 9072

    Homologous Recombination Repair Deficiency and the Immune Response in Breast Cancer: A Literature Review 

    Pellegrino, B.; Musolino, Antonio; Llop Guevara, Alba; Serra Elizalde, Violeta; De Silva, P.; Hlavata, Z. (Data de publicació: 2021-10-27)

    Càncer de mama; Immunoteràpia; Danys en l’ADN

    Implementation of an Educational Intervention for Gastric Cancer Awareness in the General Population in CELAC and Europe: A Strategy Proposed by the LEGACy Consortium 

    Carbonell-Asins, Juan; Romero, Sergio; Miralles-Marco, Ana; Lopez, Beatriz; Figueiredo, Ceu; Jiménez-Martí, Elena; García-Galea, Eduardo; Alsina, Maria (Data de publicació: 2025-10-16)

    Gastric cancer; Gastric cancer risk factors; Gastro-esophageal cancer

    Three-dimensional cell culture of chimeric antigen receptor T cells originated from peripheral blood mononuclear cells towards cellular therapies 

    Pérez del Río, Eduardo; Roman Alonso, Macarena; Rius Ruiz, Irene; Santos, Fabião; Castellote Borrell, Miquel; Veciana, Jaume; Arribas, Joaquin (Data de publicació: 2023-11-27)

    3D cell culture; CAR T cells; Adoptive cell therapy

    Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer 

    Ambrosini, Margherita; Rousseau, Benoit; Manca, Paolo; Artz, Oliver; marabelle, aurelien; André, Thierry; Elez, Elena (Data de publicació: 2024-06-27)

    POLD1 mutations; Immune checkpoint inhibitors; Metastatic colorectal cancer

    Targeting mTOR to overcome resistance to hormone and CDK4/6 inhibitors in ER-positive breast cancer models 

    Rodriguez, María Jimena; Perrone, María Cecilia; Riggio, Marina; Palafox Sánchez, Marta; Salinas, Valeria; Elia, Andres; Serra Elizalde, Violeta (Data de publicació: 2023-03-14)

    Cancer; Cell biology

    Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors 

    Joerger, Markus; Calvo, Emiliano; Laubli, Heinz; Lopez, Juanita; Alonso-Casal, Guzman; GARRALDA, Elena; Corral de la Fuente, Elena (Data de publicació: 2024-01-15)

    Solid tumors

    Germline ATM Mutations Detected by Somatic DNA Sequencing in Lethal Prostate Cancer 

    Grochot, Rafael; Carreira, Suzanne; Miranda, Susana; Figueiredo, Ines; Bertan, Claudia; Rekowski, Jan; Mateo, Joaquin (Data de publicació: 2023-06-13)

    DNA damage response; PARP inhibition; Prostate cancer

    Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trial 

    Capoluongo, Ettore Domenico; Pellegrino, B.; Califano, D.; Beltrame, L.; Serra Elizalde, Violeta; Llop Guevara, Alba; Scambia, Giovanni (Data de publicació: 2022-10-27)

    Molecular testing; Ovarian cancer

    Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer 

    Olawaiye, Alexander; Kim, Jae-Weon; Bagaméri, Andrea; Bishop, Erin; Chudecka-Głaz, Anita; Devaux, Alix; OAKNIN, ANA (Data de publicació: 2024-07-29)

    Glucocorticoid receptor; Neoplasm drug resistance; Ovarian neoplasms

    Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapy 

    Brose, Marcia; Bastholt, Lars; Führer-Sakel, Dagmar; Leboulleux, Sophie; Capdevila Castillon, Jaume; ELISEI, ROSSELLA (Data de publicació: 2024-07-09)

    Differentiated thyroid cancer; Multikinase inhibitor; Progression-free survival

    LIBRETTO-531: a phase III study of selpercatinib in multikinase inhibitor-naïve RET-mutant medullary thyroid cancer 

    Wirth, Lori J.; Brose, Marcia S; Hoff, Ana; Hu, Mimi; Capdevila Castillon, Jaume; Elisei, Rossella (Data de publicació: 2022-10-26)

    Medullary thyroid cancer; Selpercatinib; Targeted therapy

    Comprehensive Constitutional Genetic and Epigenetic Characterization of Lynch-Like Individuals 

    González-Acosta, Maribel; Vargas-Parra, Gardenia; Navarro, Matilde; Balmaña Gelpí, Judith; Ramon y Cajal, Teresa; Dámaso, Estela (Data de publicació: 2021-08-25)

    Síndrome de Lynch; Panell de gens del càncer; Epimutació

    First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion 

    Gonzalez-Martin, Antonio; Harter, Philipp; Lorusso, Domenica; Moore, Kathleen N; Oaknin Benzaquen, Ana Mazaltob; Banerjee, Susana (Data de publicació: 2021-09-20)

    Inhibidors de PARP; Càncer d’ovari avançat

    The change of paradigm in the treatment of HER2-positive breast cancer with the development of new generation antibody-drug conjugates 

    Escriva de Romaní Muñoz, Santiago Ignacio; Saura Manich, Cristina (Data de publicació: 2023-05-02)

    Breast cancer; HER2-positive; New drugs

    Imaging Response to Contemporary Immuno-oncology Combination Therapies in Patients With Metastatic Renal Cell Carcinoma 

    Ernst, Matthew; Yuasa, Takeshi; Takemura, Kosuke; Suárez Rodríguez, Cristina; Navani, Vishal; Wells, Connor; Donskov, Frede (Data de publicació: 2022-09-09)

    Combination Therapies; Metastatic Renal Cell Carcinoma

    ESMO Precision Oncology Working Group recommendations on the structure and quality indicators for molecular tumour boards in clinical practice 

    Boscolo Bielo , Luca; Aftimos, Philippe; Beltran, Himisha; Benary, Manuela; Westphalen, Benedikt; Chakravarty, Debyani; Dienstmann, Rodrigo; Mateo, Joaquin (Data de publicació: 2025-10-16)

    Molecular tumour boards; Precision medicine; Precision oncology

    Rapid mechanical phenotyping of breast cancer cells based on stochastic intracellular fluctuations 

    Cano, Álvaro; L. Yubero, Marina P.; Millá, Carmen; Puerto-Belda, Verónica; Ruz Martinez, Jose Jaime; M. Kosaka, Priscila; Malumbres, Marcos (Data de publicació: 2025-01-10)

    Cancer; Cancer systems biology

    SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocols 

    Ursino, Moreno; Dimairo, Munyaradzi; Solovyeva, Olga; Ashby, Deborah; Villacampa Javierre, Guillermo; Rekowski, Jan (Data de publicació: 2025-03-17)

    Dose escalation/de-escalation; Dose-finding; Early phase trials

    Triple blockade of EGFR, MEK and PD-L1 has antitumor activity in colorectal cancer models with constitutive activation of MAPK signaling and PD-L1 overexpression 

    Napolitano, Stefania; Matrone, Nunzia; Muddassir, A. L.; Sorokin, A.; De Falco, Vincenzo; Martini, Giulia (Data de publicació: 2021-04-20)

    Càncer colorectal; Resistència a inhibidors de MEK; Inhibidors de PD-L1

    Mast cells impair melanoma cell homing and metastasis by inhibiting HMGA1 secretion 

    Benito Martin, Alberto; Nogues, Laura; Hergueta-Redondo, Marta; Castellano-Sanz, Elena; Garvin, Eduardo; Cioffi, Michele; Villanueva Cardús, Josep (Data de publicació: 2023-05-11)

    Mast cells; Melanoma; Metastasis